2453 related articles for article (PubMed ID: 12064093)
21. Improved detection of clinically significant host-reactive antigens prior to HLA-identical sibling peripheral blood stem cell transplantation using a dendritic cell-based helper T-lymphocyte precursor assay.
Schwarer AP; Healey G; Hammett M
Bone Marrow Transplant; 2004 Feb; 33(4):367-75. PubMed ID: 14716351
[TBL] [Abstract][Full Text] [Related]
22. Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cells.
Jiang YZ; Kanfer EJ; Macdonald D; Cullis JO; Goldman JM; Barrett AJ
Bone Marrow Transplant; 1991 Oct; 8(4):253-8. PubMed ID: 1756322
[TBL] [Abstract][Full Text] [Related]
23. Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation.
Schwarer AP; Jiang YZ; Brookes PA; Barrett AJ; Batchelor JR; Goldman JM; Lechler RI
Lancet; 1993 Jan; 341(8839):203-5. PubMed ID: 8093498
[TBL] [Abstract][Full Text] [Related]
24. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
25. Pretransplant helper T-lymphocyte determination in bone marrow donors: acute graft-versus-host disease prediction and relation with long-term survival.
Winandy M; Lewalle P; Deneys V; Ferrant A; De Bruyère M
Br J Haematol; 1999 Apr; 105(1):288-94. PubMed ID: 10233396
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic T lymphocyte precursor frequency as a predictor of acute graft-versus-host disease in bone marrow transplantation from HLA-identical siblings.
Affaticati P; Locatelli F; Roggero S; Marmont F; Falda M; Dall'Omo AM; Busca A; Ceretto C; Praticò L; Berrino M; Curtoni ES
Bone Marrow Transplant; 2000 Sep; 26(5):517-23. PubMed ID: 11019841
[TBL] [Abstract][Full Text] [Related]
27. Helper T lymphocyte precursor frequency analysis in alloreactivity detection.
Cukrová V; Dolezalová L; Loudová M; Vítek A
Neoplasma; 1998; 45(1):3-6. PubMed ID: 9604993
[TBL] [Abstract][Full Text] [Related]
28. [Measurement of alloreactive anti-recipient helper T-cell precursors after allogenic bone marrow transplantation].
Dittmer R; Benn HP; Cassens U; Schwarz K; Löliger C; Zander A; Kühnl P
Beitr Infusionsther Transfusionsmed; 1994; 32():272-5. PubMed ID: 9480107
[TBL] [Abstract][Full Text] [Related]
29. Autoreactivity, backstimulation and reproducibility in a helper T lymphocyte precursor assay.
Russell CA; Petersen SL; Heilmann C; Madsen HO; Vindeløv LL
J Immunol Methods; 2001 May; 251(1-2):109-21. PubMed ID: 11292487
[TBL] [Abstract][Full Text] [Related]
30. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation.
Kaminski E; Hows J; Man S; Brookes P; Mackinnon S; Hughes T; Avakian O; Goldman JM; Batchelor JR
Transplantation; 1989 Oct; 48(4):608-13. PubMed ID: 2508280
[TBL] [Abstract][Full Text] [Related]
31. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
Al-Kasim FA; Thornley I; Rolland M; Lau W; Tsang R; Freedman MH; Saunders EF; Calderwood S; Doyle JJ
Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
[TBL] [Abstract][Full Text] [Related]
32. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD
Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494
[TBL] [Abstract][Full Text] [Related]
33. Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
Theobald M; Nierle T; Bunjes D; Arnold R; Heimpel H
N Engl J Med; 1992 Dec; 327(23):1613-7. PubMed ID: 1435898
[TBL] [Abstract][Full Text] [Related]
34. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A
Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250
[TBL] [Abstract][Full Text] [Related]
35. Frequency analysis of cytotoxic T lymphocyte precursors in search for donors in bone marrow transplantation.
Cukrová V; Dolezalová L; Loudová M; Matĕjková E; Korínková P; Lukásová M; Starý J
Neoplasma; 1995; 42(1):3-8. PubMed ID: 7617071
[TBL] [Abstract][Full Text] [Related]
36. Predicting graft-versus-host disease in HLA-identical bone marrow transplant: a comparison of T-cell frequency analysis and a human skin explant model.
Dickinson AM; Sviland L; Wang XN; Jackson G; Taylor PR; Dunn A; Proctor SJ
Transplantation; 1998 Oct; 66(7):857-63. PubMed ID: 9798694
[TBL] [Abstract][Full Text] [Related]
37. Donor helper T-cell frequencies as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
Weston LE; Geczy AF; Farrell C
Transplantation; 1997 Sep; 64(6):836-41. PubMed ID: 9326407
[TBL] [Abstract][Full Text] [Related]
38. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
Du B; Li DP; Xu KL; Pan XY
Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
[TBL] [Abstract][Full Text] [Related]
39. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
[TBL] [Abstract][Full Text] [Related]
40. High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation.
MacMillan ML; Radloff GA; Kiffmeyer WR; DeFor TE; Weisdorf DJ; Davies SM
Transplantation; 2003 Dec; 76(12):1758-62. PubMed ID: 14688528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
